Ascendis Pharma AS (MEX:ASNDN) 9-Day RSI: 69.68 (As of Jun. 25, 2026)


MEX:ASNDN Ascendis Pharma AS MEX:ASNDN
37 GF Score
Price MXN3,851.44
! 1 Warning Sign
View Full Analysis

What is Ascendis Pharma AS 9-Day RSI?

Ascendis Pharma AS MEX:ASNDN 37 9-Day RSI is 69.68 as of Jun. 25, 2026. GuruFocus rates MEX:ASNDN with a GF Score™ of 37/100. The stock has 1 warning sign investors should review. Among 1,425 Biotechnology companies, Ascendis Pharma AS ranks worse than 84.21% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-06-25), Ascendis Pharma AS's 9-Day RSI is 69.68.

The industry rank for Ascendis Pharma AS's 9-Day RSI or its related term are showing as below:

MEX:ASNDN's 9-Day RSI is ranked worse than
84.21% of 1425 companies
in the Biotechnology industry
Industry Median: 46.79 vs MEX:ASNDN: 69.68

Ascendis Pharma AS  (MEX:ASNDN) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Ascendis Pharma AS 9-Day RSI Related Terms


MEX:ASNDN vs SMMT, BBIO, JAZZ: 9-Day RSI Comparison

For the Biotechnology subindustry, Ascendis Pharma AS's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Pharma AS 9-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's 9-Day RSI falls into.


MEX:ASNDN
37GF Score
Ascendis Pharma AS MEX:ASNDN
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Pharma AS  (MEX:ASNDN) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 9-Day RSI →
What does a 9-Day RSI of 69.68 mean?
Ascendis Pharma AS (MEX:ASNDN) has a 9-Day RSI of 69.68 as of Jun. 25, 2026. According to the industry distribution chart, Ascendis Pharma AS ranks #1200 out of 1425 companies in the Biotechnology industry, placing it in the top 84.2%.
Is Ascendis Pharma AS's 9-Day RSI too high?
Ascendis Pharma AS's current 9-Day RSI is 69.68. The Biotechnology industry median 9-Day RSI is 46.79. Ascendis Pharma AS's value of 69.68 is 48.9% above this industry median. Based on the distribution chart, Ascendis Pharma AS ranks #1200 out of 1425 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's 9-Day RSI compare to SMMT and BBIO?
According to the Biotechnology industry distribution chart, Ascendis Pharma AS ranks #1200 out of 1425 companies for 9-Day RSI. This places Ascendis Pharma AS in the lower half of its industry. The industry median 9-Day RSI is 46.79. Ascendis Pharma AS's value of 69.68 is 48.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Biotechnology company?
The median 9-Day RSI among Biotechnology companies is 46.79, based on 1,425 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ascendis Pharma AS's current 9-Day RSI of 69.68 is 48.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 9-Day RSI is 46.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascendis Pharma AS's current 9-Day RSI is 69.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (MEX:ASNDN) has a current 9-Day RSI of 69.68. The current 9-Day RSI is 69.68 and 48.9% above the Biotechnology industry median of 46.79. Ascendis Pharma AS's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Ascendis Pharma AS (MEX:ASNDN), the current 9-Day RSI is 69.68 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Pharma AS Business Description

Other Exchanges ASND:USA
Address Tuborg Boulevard 12, Hellerup, DNK, 2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
37GF Score

Get the complete analysis for MEX:ASNDN

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,851.44
Price